Digital Cultivating data-driven decisions: How to use content experi... Data-driven decisions matter, and it is hardly surprising when looking at statistics.
Digital Create, approve, deploy: supercharge comms with modular cont... Each year, pharma and life sciences invest large amounts of time and money in creating content designed to attract HCPs and call them to action.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
